BIO-key International is trading at $2.65, down 10.17% on October 16, 2026, alongside a sharp software-sector selloff.
- No confirmed company-specific announcement on October 16 explains the decline. The October 13 customer announcement preceded the recent sharp rise but does not establish a reason for todayβs drop.
- IGV is down 4.65%, amid concerns about financing AI infrastructure and rising costs.
- The supplied information does not include trading volume.